English
  1. Home
  2. Stocks
  3. Indoco Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Indoco Remedies

    Small Cap
    ₹312.1
    -1.8 (-0.57%)
    • Advice
    • Hold
    23 May, 2024 20:02 BSE: 532612 NSE: INDOCOISIN: INE873D01024

    Start SIP in Indoco Remedies

    Start SIP

    Indoco Remedies Performance

    Day Range

    • Low 310
    • High 316
    ₹ 312

    52 Week Range

    • Low 308
    • High 415
    ₹ 312
    • Open Price314
    • Previous Close314
    • Volume499511

    Indoco Remedies Share Price

    • Over 1 Month -4.85%
    • Over 3 Month -17.13%
    • Over 6 Month -11.06%
    • Over 1 Year -10.26%

    Indoco Remedies Key Statistics

    P/E Ratio 29.2
    PEG Ratio -0.9
    Market Cap Cr 2,877
    Price to Book Ratio 2.6
    EPS 11.7
    Dividend 0.7
    Relative Strength Index 35.35
    Money Flow Index 30.31
    MACD Signal -4.34
    Average True Range 10.79
    Indoco Remedies Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 445449473423427
    Operating Expenses Qtr Cr 388384401360363
    Operating Profit Qtr Cr 5765726364
    Depreciation Qtr Cr 2423212018
    Interest Qtr Cr 1110889
    Tax Qtr Cr 97111013
    Net Profit Qtr Cr 3820332625
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,7991,669
    Operating Expenses Annual Cr 1,5331,382
    Operating Profit Annual in Cr 258285
    Depreciation Cr 8871
    Interest Annual Cr 3725
    Tax Annual Cr 3750
    Net Profit Annual Cr 117141
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 177176
    Cash from Investing Activity Annual Cr -302-205
    Cash from Financing Annual Activity Cr 12223
    Net Cash Flow Annual Cr -7
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,1271,027
    Fixed Assets Annual Cr 847774
    Total Non Current Assets Annual Cr 1,060853
    Total Current Assets Annual Cr 900807
    Total Assets Annual Cr 1,9611,660
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 122111
    ROE Annual % 1014
    ROCE Annual % 1318
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1517
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 450459482427428
    Operating Expenses Qtr Cr 401397410365363
    Operating Profit Qtr Cr 4963716165
    Depreciation Qtr Cr 2624212018
    Interest Qtr Cr 1210889
    Tax Qtr Cr 117111013
    Net Profit Qtr Cr 2316352426
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,8271,671
    Operating Expenses Annual Cr 1,5731,383
    Operating Profit Annual in Cr 244286
    Depreciation Cr 9271
    Interest Annual Cr 3825
    Tax Annual Cr 3951
    Net Profit Annual Cr 98142
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 157179
    Cash from Investing Activity Annual Cr -434-208
    Cash from Financing Annual Activity Cr 28023
    Net Cash Flow Annual Cr -7
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,1101,028
    Fixed Assets Annual Cr 1,058792
    Total Non Current Assets Annual Cr 1,190850
    Total Current Assets Annual Cr 955808
    Total Assets Annual Cr 2,1451,658
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 120112
    ROE Annual % 914
    ROCE Annual % 1118
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1417
    Sign Up to Know More
    Invest in Indoco Remedies

    Indoco Remedies Technicals

    EMA & SMA

    Current Price
    ₹312.1
    -1.8 (-0.57%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹324.31
    • 50 Day
    • ₹333.39
    • 100 Day
    • ₹341.81
    • 200 Day
    • ₹346.27
    • 20 Day
    • ₹325.36
    • 50 Day
    • ₹332.05
    • 100 Day
    • ₹350.83
    • 200 Day
    • ₹347.79

    Indoco Remedies Resistance and Support

    PIVOT
    ₹312.7
    Resistance
    First Resistance 315.20
    Second Resistance 318.30
    Third Resistance 320.80
    RSI 35.35
    MFI 30.31
    MACD Single Line -4.34
    MACD -5.51
    Support
    First Support 309.60
    Second Support 307.10
    Third Supoort 304.00

    Indoco Remedies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 506,543 45,472,365 89.77
    Week 200,231 13,964,082 69.74
    1 Month 151,720 9,596,296 63.25
    6 Month 166,434 8,925,867 53.63

    Indoco Remedies Result Highlights

    Indoco Remedies Synopsis

    NSE-Medical-Diversified

    Indoco Remedies is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1666.69 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2023. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.
    Market Cap 2,877
    Sales 1,791
    Shares in Float 3.78
    No of funds 82
    Yield 0.7
    Book Value 2.57
    U/D Vol ratio 0.9
    LTDebt / Equity 19
    Alpha -0.15
    Beta 1.13

    Indoco Remedies Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 58.72%58.74%58.74%58.73%
    Mutual Funds 17.91%18.17%16.61%16.91%
    Insurance Companies 0.29%0.33%0.17%0.1%
    Foreign Portfolio Investors 1.92%1.69%1.59%1.58%
    Individual Investors 15.33%15.23%16.84%16.58%
    Others 5.83%5.84%6.05%6.1%

    Indoco Remedies Management

    Name Designation
    Mr. Suresh G Kare Chairman
    Ms. Aditi Panandikar Managing Director
    Mr. Sundeep V Bambolkar Joint Managing Director
    Dr. Anand Nadkarni Non Executive Director
    Mr. D M Gavaskar Independent Director
    Mr. Rajiv P Kakodkar Independent Director
    Dr.(Ms.) Vasudha V Kamat Independent Director
    Mr. Abhijit Y Gore Independent Director

    Indoco Remedies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Indoco Remedies Corporate Action

    Date Purpose Remarks
    2024-05-16 Audited Results & Final Dividend
    2024-01-23 Quarterly Results
    2023-10-19 Quarterly Results
    2023-07-25 Quarterly Results
    2023-05-23 Audited Results & Final Dividend

    Indoco Remedies MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 50,423
    Quant Small Cap Fund Growth 20,164
    HDFC Multi Cap Fund Regular Growth 13,425
    Franklin India Smaller Companies Fund Growth 12,587
    ICICI Prudential Smallcap Fund Growth 7,659

    Indoco Remedies FAQs

    What is Share Price of Indoco Remedies ?

    Indoco Remedies share price is ₹312 As on 23 May, 2024 | 19:48

    What is the Market Cap of Indoco Remedies ?

    The Market Cap of Indoco Remedies is ₹2877 Cr As on 23 May, 2024 | 19:48

    What is the P/E ratio of Indoco Remedies ?

    The P/E ratio of Indoco Remedies is 29.2 As on 23 May, 2024 | 19:48

    What is the PB ratio of Indoco Remedies ?

    The PB ratio of Indoco Remedies is 2.6 As on 23 May, 2024 | 19:48

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.